Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reury-Perng Perng

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
American Journal of Respiratory Cell and Molecular Biology|September 24, 2005
Leukotriene C4 induces TGF-beta1 production in airway epithelium via p38 kinase pathwayDiahn-Warng Perng, Yu-Chung Wu, Kuo-Ting Chang, et al.
Journal of Critical Care|December 6, 2008
Characteristic features and outcomes of severe acute respiratory syndrome found in severe acute respiratory syndrome intensive care unit patientsTe-Cheng Lien, Chun-Sung Sung, Chen-Hsen Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL studyAlex Chang, Purvish Parikh, Sumitra Thongprasert, et al.
Journal of the Chinese Medical Association : JCMA|May 10, 2011
Third-line or fourth-line chemotherapy in non-small-cell lung cancer patients with relatively good performance statusYuh-Min Chen, Jen-Fu Shih, Wen-Chien Fan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2011
Association between tumor epidermal growth factor receptor mutation and pulmonary tuberculosis in patients with adenocarcinoma of the lungsYung-Hung Luo, Chieh-Hung Wu, Wen-Shuo Wu, et al.
American Journal of Respiratory and Critical Care Medicine|August 1, 2009
Decoy receptor 3 levels in peripheral blood predict outcomes of acute respiratory distress syndromeCheng-Yu Chen, Kuang-Yao Yang, Mei-Yu Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancerTeh-Ying Chou, Chao-Hua Chiu, Ling-Hui Li, et al.
Oncology Letters|June 29, 2012
Plasma epidermal growth factor receptor mutation analysis and possible clinical applications in pulmonary adenocarcinoma patients treated with erlotinibYuh-Min Chen, Wen-Chien Fan, Pei-Chun Tseng, et al.
Cancer|September 20, 2007
Hormone replacement therapy and lung cancer risk in ChineseKuan-Yu Chen, Chin-Fu Hsiao, Gee-Chen Chang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 14, 2011
Phase II randomized trial of erlotinib or vinorelbine in chemonaive, advanced, non-small cell lung cancer patients aged 70 years or olderYuh-Min Chen, Chun-Ming Tsai, Wen-Chien Fan, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
American Journal of Respiratory Cell and Molecular Biology|September 24, 2005
Leukotriene C4 induces TGF-beta1 production in airway epithelium via p38 kinase pathwayDiahn-Warng Perng, Yu-Chung Wu, Kuo-Ting Chang, et al.
Journal of Critical Care|December 6, 2008
Characteristic features and outcomes of severe acute respiratory syndrome found in severe acute respiratory syndrome intensive care unit patientsTe-Cheng Lien, Chun-Sung Sung, Chen-Hsen Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL studyAlex Chang, Purvish Parikh, Sumitra Thongprasert, et al.
Journal of the Chinese Medical Association : JCMA|May 10, 2011
Third-line or fourth-line chemotherapy in non-small-cell lung cancer patients with relatively good performance statusYuh-Min Chen, Jen-Fu Shih, Wen-Chien Fan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2011
Association between tumor epidermal growth factor receptor mutation and pulmonary tuberculosis in patients with adenocarcinoma of the lungsYung-Hung Luo, Chieh-Hung Wu, Wen-Shuo Wu, et al.
American Journal of Respiratory and Critical Care Medicine|August 1, 2009
Decoy receptor 3 levels in peripheral blood predict outcomes of acute respiratory distress syndromeCheng-Yu Chen, Kuang-Yao Yang, Mei-Yu Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancerTeh-Ying Chou, Chao-Hua Chiu, Ling-Hui Li, et al.
Oncology Letters|June 29, 2012
Plasma epidermal growth factor receptor mutation analysis and possible clinical applications in pulmonary adenocarcinoma patients treated with erlotinibYuh-Min Chen, Wen-Chien Fan, Pei-Chun Tseng, et al.
Cancer|September 20, 2007
Hormone replacement therapy and lung cancer risk in ChineseKuan-Yu Chen, Chin-Fu Hsiao, Gee-Chen Chang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 14, 2011
Phase II randomized trial of erlotinib or vinorelbine in chemonaive, advanced, non-small cell lung cancer patients aged 70 years or olderYuh-Min Chen, Chun-Ming Tsai, Wen-Chien Fan, et al.
Pageof 10